Global MicroRNA Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by MicroRNA Revenue
• 1.4 Market by Type
  • 1.4.1 Global MicroRNA Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 PCR-based Assay
  • 1.4.3 miRNA Arrays
  • 1.4.4 Next Generation Sequencing (NGS)
  • 1.4.5 Immunoassay
• 1.5 Market by Application
  • 1.5.1 Global MicroRNA Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostic Centers
  • 1.5.3 Academic and Research Institutes
  • 1.5.4 Biopharmaceutical Companies
  • 1.5.5 Contract Research Organizations
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global MicroRNA Market Perspective (2015-2026)
• 2.2 Global MicroRNA Growth Trends by Regions
  • 2.2.1 MicroRNA Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 MicroRNA Historic Market Share by Regions (2015-2020)
  • 2.2.3 MicroRNA Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 MicroRNA Market Growth Strategy
  • 2.3.6 Primary Interviews with Key MicroRNA Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top MicroRNA Players by Market Size
  • 3.1.1 Global Top MicroRNA Players by Revenue (2015-2020)
  • 3.1.2 Global MicroRNA Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global MicroRNA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global MicroRNA Market Concentration Ratio
  • 3.2.1 Global MicroRNA Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by MicroRNA Revenue in 2019
• 3.3 MicroRNA Key Players Head office and Area Served
• 3.4 Key Players MicroRNA Product Solution and Service
• 3.5 Date of Enter into MicroRNA Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global MicroRNA Historic Market Size by Type (2015-2020)
• 4.2 Global MicroRNA Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global MicroRNA Market Size by Application (2015-2020)
• 5.2 Global MicroRNA Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America MicroRNA Market Size (2015-2020)
• 6.2 MicroRNA Key Players in North America (2019-2020)
• 6.3 North America MicroRNA Market Size by Type (2015-2020)
• 6.4 North America MicroRNA Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe MicroRNA Market Size (2015-2020)
• 7.2 MicroRNA Key Players in Europe (2019-2020)
• 7.3 Europe MicroRNA Market Size by Type (2015-2020)
• 7.4 Europe MicroRNA Market Size by Application (2015-2020)

8 China

• 8.1 China MicroRNA Market Size (2015-2020)
• 8.2 MicroRNA Key Players in China (2019-2020)
• 8.3 China MicroRNA Market Size by Type (2015-2020)
• 8.4 China MicroRNA Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan MicroRNA Market Size (2015-2020)
• 9.2 MicroRNA Key Players in Japan (2019-2020)
• 9.3 Japan MicroRNA Market Size by Type (2015-2020)
• 9.4 Japan MicroRNA Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia MicroRNA Market Size (2015-2020)
• 10.2 MicroRNA Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia MicroRNA Market Size by Type (2015-2020)
• 10.4 Southeast Asia MicroRNA Market Size by Application (2015-2020)

11 India

• 11.1 India MicroRNA Market Size (2015-2020)
• 11.2 MicroRNA Key Players in India (2019-2020)
• 11.3 India MicroRNA Market Size by Type (2015-2020)
• 11.4 India MicroRNA Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America MicroRNA Market Size (2015-2020)
• 12.2 MicroRNA Key Players in Central & South America (2019-2020)
• 12.3 Central & South America MicroRNA Market Size by Type (2015-2020)
• 12.4 Central & South America MicroRNA Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina
  • 13.1.1 Illumina Company Details
  • 13.1.2 Illumina Business Overview
  • 13.1.3 Illumina MicroRNA Introduction
  • 13.1.4 Illumina Revenue in MicroRNA Business (2015-2020))
  • 13.1.5 Illumina Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview
  • 13.2.3 Roche MicroRNA Introduction
  • 13.2.4 Roche Revenue in MicroRNA Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Agilent
  • 13.3.1 Agilent Company Details
  • 13.3.2 Agilent Business Overview
  • 13.3.3 Agilent MicroRNA Introduction
  • 13.3.4 Agilent Revenue in MicroRNA Business (2015-2020)
  • 13.3.5 Agilent Recent Development
• 13.4 Bio-Rad
  • 13.4.1 Bio-Rad Company Details
  • 13.4.2 Bio-Rad Business Overview
  • 13.4.3 Bio-Rad MicroRNA Introduction
  • 13.4.4 Bio-Rad Revenue in MicroRNA Business (2015-2020)
  • 13.4.5 Bio-Rad Recent Development
• 13.5 Sigma Aldrich
  • 13.5.1 Sigma Aldrich Company Details
  • 13.5.2 Sigma Aldrich Business Overview
  • 13.5.3 Sigma Aldrich MicroRNA Introduction
  • 13.5.4 Sigma Aldrich Revenue in MicroRNA Business (2015-2020)
  • 13.5.5 Sigma Aldrich Recent Development
• 13.6 Qiagen
  • 13.6.1 Qiagen Company Details
  • 13.6.2 Qiagen Business Overview
  • 13.6.3 Qiagen MicroRNA Introduction
  • 13.6.4 Qiagen Revenue in MicroRNA Business (2015-2020)
  • 13.6.5 Qiagen Recent Development
• 13.7 Thermo Fisher Scientific
  • 13.7.1 Thermo Fisher Scientific Company Details
  • 13.7.2 Thermo Fisher Scientific Business Overview
  • 13.7.3 Thermo Fisher Scientific MicroRNA Introduction
  • 13.7.4 Thermo Fisher Scientific Revenue in MicroRNA Business (2015-2020)
  • 13.7.5 Thermo Fisher Scientific Recent Development
• 13.8 HTG Molecular Diagnostics
  • 13.8.1 HTG Molecular Diagnostics Company Details
  • 13.8.2 HTG Molecular Diagnostics Business Overview
  • 13.8.3 HTG Molecular Diagnostics MicroRNA Introduction
  • 13.8.4 HTG Molecular Diagnostics Revenue in MicroRNA Business (2015-2020)
  • 13.8.5 HTG Molecular Diagnostics Recent Development
• 13.9 Meridian Life Science
  • 13.9.1 Meridian Life Science Company Details
  • 13.9.2 Meridian Life Science Business Overview
  • 13.9.3 Meridian Life Science MicroRNA Introduction
  • 13.9.4 Meridian Life Science Revenue in MicroRNA Business (2015-2020)
  • 13.9.5 Meridian Life Science Recent Development
• 13.10 Rosetta Genomics
  • 13.10.1 Rosetta Genomics Company Details
  • 13.10.2 Rosetta Genomics Business Overview
  • 13.10.3 Rosetta Genomics MicroRNA Introduction
  • 13.10.4 Rosetta Genomics Revenue in MicroRNA Business (2015-2020)
  • 13.10.5 Rosetta Genomics Recent Development
• 13.11 Dharmacon
  • 10.11.1 Dharmacon Company Details
  • 10.11.2 Dharmacon Business Overview
  • 10.11.3 Dharmacon MicroRNA Introduction
  • 10.11.4 Dharmacon Revenue in MicroRNA Business (2015-2020)
  • 10.11.5 Dharmacon Recent Development
• 13.12 BioVendor
  • 10.12.1 BioVendor Company Details
  • 10.12.2 BioVendor Business Overview
  • 10.12.3 BioVendor MicroRNA Introduction
  • 10.12.4 BioVendor Revenue in MicroRNA Business (2015-2020)
  • 10.12.5 BioVendor Recent Development
• 13.13 Miltenyi Biotec
  • 10.13.1 Miltenyi Biotec Company Details
  • 10.13.2 Miltenyi Biotec Business Overview
  • 10.13.3 Miltenyi Biotec MicroRNA Introduction
  • 10.13.4 Miltenyi Biotec Revenue in MicroRNA Business (2015-2020)
  • 10.13.5 Miltenyi Biotec Recent Development
• 13.14 Kaneka Corporation
  • 10.14.1 Kaneka Corporation Company Details
  • 10.14.2 Kaneka Corporation Business Overview
  • 10.14.3 Kaneka Corporation MicroRNA Introduction
  • 10.14.4 Kaneka Corporation Revenue in MicroRNA Business (2015-2020)
  • 10.14.5 Kaneka Corporation Recent Development
• 13.15 Abcam
  • 10.15.1 Abcam Company Details
  • 10.15.2 Abcam Business Overview
  • 10.15.3 Abcam MicroRNA Introduction
  • 10.15.4 Abcam Revenue in MicroRNA Business (2015-2020)
  • 10.15.5 Abcam Recent Development
• 13.16 GeneCopoeia
  • 10.16.1 GeneCopoeia Company Details
  • 10.16.2 GeneCopoeia Business Overview
  • 10.16.3 GeneCopoeia MicroRNA Introduction
  • 10.16.4 GeneCopoeia Revenue in MicroRNA Business (2015-2020)
  • 10.16.5 GeneCopoeia Recent Development
• 13.17 Promega Corporation
  • 10.17.1 Promega Corporation Company Details
  • 10.17.2 Promega Corporation Business Overview
  • 10.17.3 Promega Corporation MicroRNA Introduction
  • 10.17.4 Promega Corporation Revenue in MicroRNA Business (2015-2020)
  • 10.17.5 Promega Corporation Recent Development
• 13.18 New England Biolabs
  • 10.18.1 New England Biolabs Company Details
  • 10.18.2 New England Biolabs Business Overview
  • 10.18.3 New England Biolabs MicroRNA Introduction
  • 10.18.4 New England Biolabs Revenue in MicroRNA Business (2015-2020)
  • 10.18.5 New England Biolabs Recent Development
• 13.19 NanoString Technologies
  • 10.19.1 NanoString Technologies Company Details
  • 10.19.2 NanoString Technologies Business Overview
  • 10.19.3 NanoString Technologies MicroRNA Introduction
  • 10.19.4 NanoString Technologies Revenue in MicroRNA Business (2015-2020)
  • 10.19.5 NanoString Technologies Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer